A Multiple-dose Study to Evaluate the Tolerability and Pharmacokinetics of Ammoxetine Hydrochloride Enteric-coated Tablets in Chinese Healthy Subjects
Latest Information Update: 04 Feb 2021
At a glance
- Drugs Ammuxetine hydrochloride-CSPC Zhongqi Pharmaceutical Technology (Primary)
- Indications Major depressive disorder
- Focus Adverse reactions; Pharmacokinetics
- Sponsors CSPC ZhongQi Pharmaceutical Technology
Most Recent Events
- 04 May 2020 New trial record
- 20 Feb 2019 Status changed from planning to not yet recruiting.